Nantahala Capital Management - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T209. A total of 31 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,773,342
-13.6%
1,992,5190.0%0.10%
-11.1%
Q1 2024$2,052,295
-29.9%
1,992,519
-50.0%
0.12%
+34.5%
Q4 2023$2,929,002
+161.9%
3,985,038
+106.7%
0.09%
-8.4%
Q3 2023$1,118,2491,928,0150.10%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Rosalind Advisors, Inc. 758,966$675,4800.52%
Nantahala Capital Management 1,992,519$1,773,3420.10%
Values First Advisors, Inc. 113,175$100,7250.06%
Turtle Creek Wealth Advisors, LLC 71,500$63,6350.02%
Rock Springs Capital Management LP 316,460$281,6490.01%
UNITED BANK 14,800$13,1720.00%
MAI Capital Management 283,992$252,7530.00%
WELLS FARGO & COMPANY/MN 775$6900.00%
NORTHERN TRUST CORP 10,891$9,6930.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACELRX PHARMACEUTICALS INC shareholders